Global patent index - EP 0979106 A1

EP 0979106 A1 2000-02-16 - USE OF A MODIFIED BACULOVIRUS CONTAINING EXOGENOUS NUCLEIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR DELIVERING SAID NUCLEIC ACID TO THE HEPATOCYTES

Title (en)

USE OF A MODIFIED BACULOVIRUS CONTAINING EXOGENOUS NUCLEIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR DELIVERING SAID NUCLEIC ACID TO THE HEPATOCYTES

Title (de)

VERWENDUNG VON MODIFIZIERTEM BACULOVIRUS ENTHALTEND EXOGENE NUKLEINSÄUREN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR ABGABE DIESER NUKLEINSÄUREN AN HEPATOZYTEN

Title (fr)

UTILISATION D'UN BACULOVIRUS MODIFIE CONTENANT UN ACIDE NUCLEIQUE EXOGENE POUR PREPARER UN MEDICAMENT SERVANT A ADMINISTRER LEDIT ACIDE NUCLEIQUE AUX HEPATOCYTES

Publication

EP 0979106 A1 (EN)

Application

EP 98919340 A

Priority

  • GB 9801249 W
  • GB 9708698 A

Abstract (en)

[origin: WO9848842A1] Modified baculovirus particles containing prophylactic and/or therapeutic nucleic acid are provided, together with their use in treating liver conditions such as viral infections.

IPC 1-7 (main, further and additional classification)

A61K 48/00; C12N 15/86

IPC 8 full level (invention and additional information)

A61K 48/00 (2006.01); C12N 15/866 (2006.01)

CPC (invention and additional information)

C12N 15/86 (2013.01); A61K 48/00 (2013.01); C12N 2710/14143 (2013.01)

Citation (search report)

See references of WO 9848842A1

Designated contracting state (EPC)

BE DE ES FR GB IT NL

EPO simple patent family

WO 9848842 A1 19981105; AU 7221798 A 19981124; EP 0979106 A1 20000216; GB 9708698 D0 19970618

INPADOC legal status

2002-07-03 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20011222

2001-07-25 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20010611

2000-02-16 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 19991129

2000-02-16 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): BE DE ES FR GB IT NL